• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Novel reassortant H7N2 originating from the H7N9 highly pathogenic avian influenza viruses in China, 2019

tetano

Editor, Senior Moderator
J Infect. 2019 Aug 29. pii: S0163-4453(19)30256-7. doi: 10.1016/j.jinf.2019.08.016. [Epub ahead of print]
[h=1]Novel reassortant H7N2 originating from the H7N9 highly pathogenic avian influenza viruses in China, 2019.[/h] Qiu Y[SUP]1[/SUP], Sun R[SUP]2[/SUP], Hou G[SUP]2[/SUP], Yu X[SUP]2[/SUP], Li Y[SUP]2[/SUP], Li J[SUP]2[/SUP], Zhang Q[SUP]1[/SUP], Zou F[SUP]1[/SUP], Liu H[SUP]2[/SUP], Jiang W[SUP]3[/SUP].
[h=3]Author information[/h] 1 Guangdong Key Laboratory of Animal Conservation and Resource Utilization, Guangdong Public Laboratory of Wild Animal Conservation and Utilization, Guangdong Institute of Applied Biological Resources, Guangzhou, China. 2 China Animal Health and Epidemiology Center, Qingdao, China. 3 China Animal Health and Epidemiology Center, Qingdao, China. Electronic address: civcul@163.com.

[h=3]Abstract[/h] In March 2013, the first human case of zoonotic H7N9 avian influenza virus (AIV) infection was reported in China. This virus has been circulating in domestic poultry in China while mutating to highly pathogenic AIV (HPAIV) since 2017, which caused human infections and poultry outbreaks. In 2019, a novel reassortant H7N2 HPAIV, A/chicken/China/SJZ1/2019(SJZ1), was isolated from H7-Re2-vaccinated layers. We analyzed the genetic, pathogenic, and antigenic characteristics of SJZ1. Analysis of the entire SJZ1 genomic sequence revealed that it comprised at least two different sources; the PB2, PB1, PA, HA (H7), M, and NS segments of SJZ1 were directly derived from H7N9 AIVs, whereas the NA (N2) and NP segments of SJZ1 were derived from H9N2 AIVs. Experimental infection revealed that SJZ1 was highly pathogenic in chickens but not in ducks. SJZ1 was shed from and replicated in chickens and ducks. Hemagglutination-inhibition assay and challenge test indicated that SJZ1 exhibited rapid antigenic drift and distinct antigenicity relative to the H7-Re2 vaccine strain, which provides poor protection for SJZ1. Our study reports the emergence of a new reassortant of H7N2 AIV with novel viral characteristics and warns of the challenge we still face to control the zoonotic H7N9 AIVs and their reassortants.
Copyright ? 2019. Published by Elsevier Ltd.


[h=4]KEYWORDS:[/h] Antigenic drift; Chickens; Ducks; H7N2; H7N9; Pathogenicity

PMID: 31473272 DOI: 10.1016/j.jinf.2019.08.016
 
Back
Top Bottom